Clinical Trials Browser

Phase 1 × Not yet recruiting × Solid Tumor × Clear all

NCT05954091 2024-12-27

OH2 Administered by Intratumoral Injection

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumor